...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Practice of Comparative Effectiveness Research to Identify Treatment Characteristics of Similar Chinese Patent Medicine for Angina Pectoris
【24h】

Practice of Comparative Effectiveness Research to Identify Treatment Characteristics of Similar Chinese Patent Medicine for Angina Pectoris

机译:比较效果研究的实践,以鉴定阿心绞痛同源中药治疗特征的实践

获取原文
获取原文并翻译 | 示例

摘要

Objective. Individualized application of TCM is not easy and may lead to undesirable results, such as poor effect or even adverse reactions. This trial aims to compare two common Chinese patent medicines with similar effects. Background of the Research. Four hospitals carried out the test at the same time in Tianjin city of China. Participants. 144 patients were involved in this study; all patients must meet the diagnostic criteria. Interventions. Qishen Yiqi pills, compound danshen pills, and their placebos; an efficacy analysis was conducted after the first medication and after crossover medication. Primary Outcome Measures. The primary index of end point includes Seattle Angina Questionnaire score-7 and score of 7-point Likert Scale; the curative effect was compared with minimal clinically important differences value. Result. Two drugs have their respective advantages in treating SAP. In practical application, the two drugs shall be discriminated in use based on patients' specific symptoms.
机译:客观的。个体化的TCM应用并不容易,可能导致不良结果,例如效果差或甚至不良反应。该试验旨在比较两个具有类似效果的普通中型药物。研究的背景。四家医院在中国天津市同时进行了考验。参与者。 144名患者参与了这项研究;所有患者必须符合诊断标准。干预措施。 Qishen yiqi药丸,复合丹参丸,及其安放;在第一药物和交叉药物后进行疗效分析。主要结果措施。终点的主要指数包括西雅图昂首南问卷评分-7和7点李克特量表的得分;将疗效与最小临床上重要的差异值进行比较。结果。两种药物在治疗SAP方面具有各自的优势。在实际应用中,基于患者的特异性症状,应在使用中歧视两种药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号